Which blood pressure monitor is best for heart surgery patients? study aims to find out.

NCT ID NCT06828432

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Hernando Gomez Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will enroll 50 adults recovering from open-heart surgery to test three FDA-approved, non-invasive devices (ClearSight, CareTaker, and CNAP) that measure blood pressure and how well the heart pumps blood. The goal is to see which device is most accurate compared to standard invasive monitors. The results could help doctors use safer, non-invasive tools to guide treatment in intensive care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: non-invasive hemodynamic monitoring devices (ClearSight, CareTaker, CNAP)
What this could lead to: If successful, this study could show which non-invasive monitor is most accurate, potentially reducing the need for riskier invasive monitoring in heart surgery patients.
What could go wrong: This is a small, early-stage validation study (50 participants) that only tests accuracy, not patient outcomes. The devices may not prove reliable enough to replace current methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPEN HEART SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPEN HEART SURGERY

Contacts and locations

Locations

University Pittsburgh Medical Center

Pittsburgh, Pennsylvania, 15213, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.